Ja. Weiner et al., LYSOPHOSPHATIDIC ACID RECEPTOR GENE VZG-1 LP(A1)/EDG-2 IS EXPRESSED BY MATURE OLIGODENDROCYTES DURING MYELINATION IN THE POSTNATAL MURINE BRAIN/, Journal of comparative neurology, 398(4), 1998, pp. 587-598
The growth-factor-like phospholipid lysophosphatidic acid (LPA) mediat
es a wide variety of biological functions. We recently reported the cl
oning of the first G-protein-coupled receptor for LPA, called ventricu
lar zone gene-1 (vzg-1/lp(A1)/edg-2) because its embryonic central ner
vous system (CNS) expression is restricted to the neocortical ventricu
lar zone (Hecht et al. [1996] J. Cell Biol. 135:1071-1083). Vzg-1 neur
al expression diminishes at the end of the cortical neurogenetic perio
d, just before birth. Here, we have investigated the subsequent reappe
arance of vzg-1 expression in the postnatal murine brain, by using in
situ hybridization and northern blot analyses. Vzg-1 expression was un
detectable by in situ hybridization at birth, but reappeared in the hi
ndbrain during the 1st postnatal week. Subsequently, expression expand
ed from caudal to rostral, with peak expression observed around postna
tal day 18. At all postnatal ages, vzg-1 expression was concentrated i
n and around developing white matter tracts, and its expansion, peak,
and subsequent downregulation closely paralleled the progress of myeli
nation. Double-label in situ hybridization studies demonstrated that v
zg-1-expressing cells co-expressed mRNA encoding proteolipid protein (
PLP), a mature oligodendrocyte marker, but not glial fibrillary acidic
protein (GFAP), an astrocyte marker. Consistent with this, vzg-1 mRNA
expression was reduced by 40% in the brains of jimpy mice, which exhi
bit aberrant oligodendrocyte differentiation and cell death. Together
with our characterization of vzg-1 during cortical neurogenesis, these
data suggest distinct pre- and postnatal roles for LPA in the develop
ment of neurons and oligodendrocytes and implicate lysophospholipid si
gnaling as a potential regulator of myelination. J. Comp. Neurol. 398:
587-598, 1998. (C) 1998 Wiley-Liss, Inc.